Cystic fibrosis is a genetic condition that affects the lungs and digestive system, often leading to breathing difficulties and recurring infections. Trikafta medication has become an important treatment option for many people living with this condition. It works by targeting the underlying protein defect linked to cystic fibrosis instead of only treating symptoms.
Cystic fibrosis is a long term genetic disorder that mainly affects the lungs, pancreas, and digestive system. People living with this condition often experience thick mucus buildup, breathing problems, and frequent lung infections. Medical advancements have introduced treatments that target the root cause of the disease, and Trikafta medication is one of the most recognized options available today.